Research progress of sepsis-induced acute kidney injury.
10.3760/cma.j.issn.2095-4352.2018.07.018
- Author:
Shiyong ZENG
1
,
2
;
Jinle LIN
;
Wenwu ZHANG
Author Information
1. Department of Emergency, Affiliated Baoan People's Hospital of Shenzhen, Southern Medical University, Shenzhen 518101, Guangdong, China (Zeng SY, Lin JL, Zhang WW)
2. Graduate School of Guangdong Medical University, Zhanjiang 524001, Guangdong, China (Zeng SY). Corresponding author: Zhang Wenwu, Email: zww5@sina.com.
- Publication Type:Review
- MeSH:
Acute Kidney Injury;
Biomarkers;
Creatinine;
Humans;
Kidney;
Sepsis
- From:
Chinese Critical Care Medicine
2018;30(7):703-707
- CountryChina
- Language:Chinese
-
Abstract:
Acute kidney injury (AKI) is a common complication in patients with sepsis, with poor prognosis and high mortality. The pathogenesis of sepsis-induced acute kidney injury (SAKI) is closely related to renal hemodynamic abnormalities, inflammatory injury and adaptive mechanism. It is insufficient for previous criteria based on urine output and creatinine to the early diagnosis of SAKI. The emergence of new biomarkers may make up for deficiencies in early diagnosis. And significant progress has also been made in the treatment of SAKI. The aim of this article was to review the researches on pathophysiology, early diagnosis and treatment of SAKI and provides some help for clinical staff to understand SAKI.
